Zhao Yu Lin - Net Worth and Insider Trading

Zhao Yu Lin Net Worth

The estimated net worth of Zhao Yu Lin is at least $4 Million dollars as of 2025-06-27. Zhao Yu Lin is the Secretary Dong of Pacific Shuanglin Bio-pharmacy Co Ltd and owns about 244,920 shares of Pacific Shuanglin Bio-pharmacy Co Ltd (SZSE:000403) stock worth over $4 Million. Details can be seen in Zhao Yu Lin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Zhao Yu Lin has not made any transactions after 2025-04-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Zhao Yu Lin

Zhao Yu Lin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Zhao Yu Lin owns 1 companies in total, including Pacific Shuanglin Bio-pharmacy Co Ltd (SZSE:000403) .

Click here to see the complete history of Zhao Yu Lin’s form 4 insider trades.

Insider Ownership Summary of Zhao Yu Lin

Ticker	Company	Transaction Date	Type of Owner
SZSE:000403	Pacific Shuanglin Bio-pharmacy Co Ltd	2025-04-25	Secretary Dong

Zhao Yu Lin Latest Holdings Summary

Zhao Yu Lin currently owns a total of 1 stock. Zhao Yu Lin owns 244,920 shares of Pacific Shuanglin Bio-pharmacy Co Ltd (SZSE:000403) as of April 25, 2025, with a value of $4 Million.

Latest Holdings of Zhao Yu Lin

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SZSE:000403	Pacific Shuanglin Bio-pharmacy Co Ltd	2025-04-25	244,920	18.27	4,474,688

Holding Weightings of Zhao Yu Lin

Zhao Yu Lin Form 4 Trading Tracker

According to the SEC Form 4 filings, Zhao Yu Lin has made a total of 8 transactions in Pacific Shuanglin Bio-pharmacy Co Ltd (SZSE:000403) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in Pacific Shuanglin Bio-pharmacy Co Ltd is the acquisition of 9,750 shares on April 25, 2025, which cost Zhao Yu Lin around $163,125.

Insider Trading History of Zhao Yu Lin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Zhao Yu Lin Trading Performance

GuruFocus tracks the stock performance after each of Zhao Yu Lin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Zhao Yu Lin is 6.21%. GuruFocus also compares Zhao Yu Lin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Zhao Yu Lin within 3 months outperforms 6 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Zhao Yu Lin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Zhao Yu Lin

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	2.51
Relative Return to S&P 500(%)	4.16

Zhao Yu Lin Ownership Network

Ownership Network List of Zhao Yu Lin

No Data

Ownership Network Relation of Zhao Yu Lin

Zhao Yu Lin Owned Company Details

What does Pacific Shuanglin Bio-pharmacy Co Ltd do?

Who are the key executives at Pacific Shuanglin Bio-pharmacy Co Ltd?

Zhao Yu Lin is the Secretary Dong of Pacific Shuanglin Bio-pharmacy Co Ltd. Other key executives at Pacific Shuanglin Bio-pharmacy Co Ltd include Executives Wang Ye Hong , Supervisors zuo chao , and Directors & executives ye lan .

Pacific Shuanglin Bio-pharmacy Co Ltd (SZSE:000403) Insider Trades Summary

Over the past 18 months, Zhao Yu Lin made 6 insider transaction in Pacific Shuanglin Bio-pharmacy Co Ltd (SZSE:000403) with a net purchase of 24,500. Other recent insider transactions involving Pacific Shuanglin Bio-pharmacy Co Ltd (SZSE:000403) include a net purchase of 47,500 shares made by rong xian kui , a net purchase of 24,300 shares made by guo hui , and a net purchase of 24,000 shares made by ye lan .

In summary, during the past 3 months, insiders sold 0 shares of Pacific Shuanglin Bio-pharmacy Co Ltd (SZSE:000403) in total and bought 73,060 shares, with a net purchase of 73,060 shares. During the past 18 months, 3,418,999 shares of Pacific Shuanglin Bio-pharmacy Co Ltd (SZSE:000403) were sold and 281,580 shares were bought by its insiders, resulting in a net sale of 3,137,419 shares.

Pacific Shuanglin Bio-pharmacy Co Ltd (SZSE:000403)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pacific Shuanglin Bio-pharmacy Co Ltd Insider Transactions

No Available Data

Zhao Yu Lin Mailing Address

Above is the net worth, insider trading, and ownership report for Zhao Yu Lin. Currently GuruFocus does not have mailing address information for Zhao Yu Lin.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.